SCHEMBL6447854

SCHEMBL6447854

C=CC(=O)OC(C)(c1cc(C(C)(C)CC)cc(C(C)(C)CC)c1O)c1cc(C(C)(C)CC)cc(C(C)(C)CC)c1O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RXRA P19793 5/20 0.35
▸ PPARG P37231 5/20 0.35
▸ RARG P13631 4/20 0.35
▸ GAA P10253 1/20 0.33
▸ RARA P10276 1/20 0.32
▸ RARB P10826 1/20 0.32
▸ RXRB P28702 1/20 0.32
▸ RXRG P48443 1/20 0.32
▸ NPC1 O15118 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ CYP2C9 P11712 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ THRB P10828 2/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8878210 0.80 GAA (0.41) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL7191459 0.78 RXRA (0.36) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL1160345 0.77 SMN1; SMN2 (0.41) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL27242779 0.77 RXRA (0.38) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL1160149 0.75 RXRA (0.36) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL29842995 0.75 RXRA (0.36) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL2612511 0.75 RXRA (0.36) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL11797744 0.75 CA1 (0.44) MEN1ALDH1A1MAPK1KMT2ANPSR1
SCHEMBL17471442 0.74 RXRA (0.41) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2
SCHEMBL237192 0.73 RXRA (0.37) MEN1ALDH1A1MAPK1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3000831-B1 PHOTOCURABLE ACRYLIC-BASED THERMAL CONDUCTIVE COMPOSITION, ACRYLIC-BASED THERMAL CONDUCTIVE SHEET, AND METHOD OF PRODUCING THE SAME DEXERIALS CORP (JP) 2018-11-07 — — EP claimed
US-9416254-B2 Photocurable acrylic-based thermal conductive composition, acrylic-based thermal conductive sheet, and method of producing the same DEXERIALS CORPORATION (JP) 2016-08-16 — — US claimed
EP-3000831-A1 PHOTOCURABLE ACRYLIC THERMO-CONDUCTING COMPOSITION, ACRYLIC THERMOCONDUCTIVE SHEET, AND METHOD FOR MANUFACTURING SAME Dexerials Corporation (JP) 2016-03-30 — — EP claimed
US-20160024279-A1 PHOTOCURABLE ACRYLIC-BASED THERMAL CONDUCTIVE COMPOSITION, ACRYLIC-BASED THERMAL CONDUCTIVE SHEET, AND METHOD OF PRODUCING THE SAME DEXERIALS CORPORATION (JP) 2016-01-28 — — US claimed
US-20210062107-A1 STABILIZED CANDLE WAX COMPOSITIONS MPT INC (US) 2021-03-04 — — US disclosed
EP-3000831-B1 PHOTOCURABLE ACRYLIC-BASED THERMAL CONDUCTIVE COMPOSITION, ACRYLIC-BASED THERMAL CONDUCTIVE SHEET, AND METHOD OF PRODUCING THE SAME DEXERIALS CORP (JP) 2018-11-07 — — EP disclosed
US-9416254-B2 Photocurable acrylic-based thermal conductive composition, acrylic-based thermal conductive sheet, and method of producing the same DEXERIALS CORPORATION (JP) 2016-08-16 — — US disclosed
EP-3000831-A1 PHOTOCURABLE ACRYLIC THERMO-CONDUCTING COMPOSITION, ACRYLIC THERMOCONDUCTIVE SHEET, AND METHOD FOR MANUFACTURING SAME Dexerials Corporation (JP) 2016-03-30 — — EP disclosed
US-20160024279-A1 PHOTOCURABLE ACRYLIC-BASED THERMAL CONDUCTIVE COMPOSITION, ACRYLIC-BASED THERMAL CONDUCTIVE SHEET, AND METHOD OF PRODUCING THE SAME DEXERIALS CORPORATION (JP) 2016-01-28 — — US disclosed
US-6861552-B2 Adamantyl ester monomer composition TOKUYAMA CORPORATION (JP) 2005-03-01 — — US disclosed
US-20040015008-A1 Adamantyl ester monomer composition TOKUYAMA CORPORATION (JP) 2004-01-22 — — US disclosed
EP-1306363-A1 ADAMANTYL ESTER MONOMER COMPOSITION TOKUYAMA CORPORATION (JP) 2003-05-02 — — EP disclosed
US-5602196-A OXIDATION AND HEAT RESISTANCE; PHOTOSTABILITY CIBA-GEIGY CORPORATION (US) 1997-02-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040015008-A1 Adamantyl ester monomer composition PRMT1, HSD11B1, HSD3B1 MEN1 107/4885ALDH1A1 192/4885MAPK1 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback